The Genomics Platform, created within our NCCR and located in Geneva, provides counselling and access to the state-of-the-art methods in genomic technologies.
These enable to monitor gene expression (including mRNA, miRNA, non coding RNA), to discover new genes, to determine genotypes and⁄or to analyze results of protein-DNA and DNA-DNA interactions at the scale of whole genomes and with a very high throughput.
They provide detailed insight into the cellular processes involved in the regulation of gene expression and global genome organization.
We propose various techniques to perform RNA and DNA quantification and analysis (e.g transcriptome profiling, gene discovery, genotyping, chromatin IP’s, etc.), while continuing to develop and improve the methods proposed.
| |
|
|
| |
NanoString Technologies news
|
Genomics Platform and NanoString: research collaboration agreement - Interview with Dr Patrick Descombes, Manager of the Genomics Platform, in The NanoString Reporter.
|
|
›› Details
|
|
NanoString launches Human miRNA Expression Assay Kit to monitor more than 700 human and human-associated viral miRNAs derived from miRBase.
|
|
›› Details
|
|
|
| |
|
|
| |
|
|
| |
New equipment and service at the Genomics Platform
Illumina Genome Analyzer IIx
Next generation sequencing (also kwown as “Ultra high throughput sequencing”) on Illumina Genome Analyzer IIx is available now at the Genomics Platform.
|
|
|
›› Details
|
|
|
|
| |
|
|
|